# Amrize Ltd. (AMRZ)

**Exchange:** NYSE  
**Market cap:** $28.12B  
**Price:** $50.80 (-5.19%)

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $11.81B | $3.03B | $1.91B | $1.19B | — |
| 2024 | $11.70B | $3.07B | $2.19B | $1.27B | — |
| 2023 | $11.68B | $2.77B | $1.89B | $956M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $24.25B | $10.99B | $13.26B | $1.92B | $4.94B |
| 2024 | $23.80B | $13.89B | $9.91B | $1.58B | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $2.21B | $788M | $1.42B |
| 2024 | $2.28B | $642M | $1.64B |
| 2023 | $2.04B | $630M | $1.41B |

Source: [CompaniesByCap](https://companiesbycap.com/company/AMRZ)
